Tokai
Pharmaceuticals, Inc., a biopharmaceutical company focused on
developing new treatments for prostate cancer, today announced that
clinical data from the ARMOR1 ... read more
Tokai
Pharmaceuticals, Inc., a biopharmaceutical company focused on
developing new treatments for prostate cancer, today announced that
Martin D. Williams, president and ... read more
Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on
developing new treatments for prostate cancer, today announced that new
preclinical data demonstrating the differentiated potent and selective
... read more
Tokai
Pharmaceuticals, Inc., a biopharmaceutical company focused on
developing new treatments for prostate cancer, today announced the
treatment of the first patient ... read more